
Single psilocybin trip delivers two years of depression relief for cancer patients
New results from a clinical trial reveal that a single dose of psilocybin — a naturally occurring psychedelic compound found in mushrooms — can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American…